Ikena Oncology IncNASDAQ:IKNA
- LAST PRICE1.3300
- TODAY'S CHANGE (%)0.0700 (5.5556%)
- Bid / Lots1.2600/ 4
- Ask / Lots1.3600/ 4
- Open / Previous Close1.2500 / 1.2600
- Day Range
- 52 Week Range
- Volume334,007
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IKNA |
|---|---|---|
| 09:32 ET | 5629 | 1.25 |
| 09:34 ET | 200 | 1.25 |
| 09:41 ET | 100 | 1.265 |
| 09:48 ET | 7000 | 1.27 |
| 09:50 ET | 100 | 1.28 |
| 09:52 ET | 200 | 1.29 |
| 09:54 ET | 6090 | 1.275 |
| 09:56 ET | 9250 | 1.25 |
| 09:59 ET | 400 | 1.29 |
| 10:03 ET | 112656 | 1.26 |
| 10:06 ET | 300 | 1.28 |
| 10:08 ET | 100 | 1.27 |
| 10:10 ET | 200 | 1.28 |
| 10:15 ET | 300 | 1.28 |
| 10:17 ET | 400 | 1.28 |
| 10:21 ET | 200 | 1.28 |
| 10:26 ET | 1650 | 1.27 |
| 10:32 ET | 900 | 1.27 |
| 10:33 ET | 2300 | 1.26 |
| 10:35 ET | 600 | 1.27 |
| 10:39 ET | 100 | 1.27 |
| 10:42 ET | 200 | 1.28 |
| 10:44 ET | 10944 | 1.27 |
| 10:48 ET | 600 | 1.275 |
| 10:50 ET | 648 | 1.275 |
| 10:53 ET | 200 | 1.29 |
| 10:55 ET | 140 | 1.26 |
| 11:00 ET | 462 | 1.29 |
| 11:02 ET | 100 | 1.275 |
| 11:06 ET | 200 | 1.29 |
| 11:08 ET | 100 | 1.275 |
| 11:09 ET | 2550 | 1.29 |
| 11:11 ET | 100 | 1.29 |
| 11:13 ET | 300 | 1.29 |
| 11:18 ET | 100 | 1.275 |
| 11:20 ET | 2771 | 1.29 |
| 11:22 ET | 1664 | 1.29 |
| 11:24 ET | 100 | 1.29 |
| 11:26 ET | 369 | 1.3 |
| 11:27 ET | 100 | 1.29 |
| 11:29 ET | 648 | 1.28 |
| 11:31 ET | 200 | 1.29 |
| 11:33 ET | 101 | 1.29 |
| 11:36 ET | 100 | 1.3 |
| 11:38 ET | 500 | 1.29 |
| 11:40 ET | 700 | 1.28 |
| 11:42 ET | 300 | 1.285 |
| 11:44 ET | 500 | 1.285 |
| 11:45 ET | 200 | 1.285 |
| 11:47 ET | 11997 | 1.285 |
| 11:49 ET | 100 | 1.28 |
| 11:54 ET | 200 | 1.285 |
| 11:56 ET | 399 | 1.28 |
| 11:58 ET | 100 | 1.28 |
| 12:00 ET | 100 | 1.285 |
| 12:02 ET | 2361 | 1.26 |
| 12:03 ET | 100 | 1.26 |
| 12:07 ET | 100 | 1.275 |
| 12:09 ET | 600 | 1.27 |
| 12:12 ET | 100 | 1.26 |
| 12:14 ET | 108 | 1.27 |
| 12:18 ET | 1865 | 1.25 |
| 12:21 ET | 100 | 1.26 |
| 12:25 ET | 100 | 1.25 |
| 12:27 ET | 300 | 1.25 |
| 12:34 ET | 300 | 1.26 |
| 12:38 ET | 1800 | 1.26 |
| 12:39 ET | 7438 | 1.26 |
| 12:45 ET | 271 | 1.26 |
| 12:50 ET | 1100 | 1.26 |
| 12:54 ET | 100 | 1.26 |
| 01:03 ET | 1274 | 1.27 |
| 01:06 ET | 148 | 1.26 |
| 01:10 ET | 100 | 1.26 |
| 01:12 ET | 100 | 1.27 |
| 01:15 ET | 1067 | 1.27 |
| 01:17 ET | 200 | 1.2695 |
| 01:19 ET | 100 | 1.27 |
| 01:21 ET | 2097 | 1.28 |
| 01:24 ET | 100 | 1.29 |
| 01:28 ET | 200 | 1.29 |
| 01:30 ET | 163 | 1.28 |
| 01:32 ET | 100 | 1.29 |
| 01:33 ET | 2158 | 1.28 |
| 01:37 ET | 230 | 1.28 |
| 01:46 ET | 193 | 1.28 |
| 01:51 ET | 621 | 1.28 |
| 01:55 ET | 101 | 1.2725 |
| 02:00 ET | 702 | 1.28 |
| 02:02 ET | 200 | 1.28 |
| 02:04 ET | 103 | 1.28 |
| 02:06 ET | 5414 | 1.29 |
| 02:08 ET | 4297 | 1.29 |
| 02:09 ET | 279 | 1.28 |
| 02:11 ET | 3663 | 1.28 |
| 02:13 ET | 461 | 1.27 |
| 02:15 ET | 100 | 1.29 |
| 02:18 ET | 200 | 1.28 |
| 02:22 ET | 185 | 1.28 |
| 02:24 ET | 100 | 1.28 |
| 02:26 ET | 300 | 1.28 |
| 02:29 ET | 400 | 1.29 |
| 02:31 ET | 200 | 1.29 |
| 02:38 ET | 100 | 1.28 |
| 02:40 ET | 100 | 1.29 |
| 02:42 ET | 2703 | 1.27 |
| 02:44 ET | 100 | 1.27 |
| 02:47 ET | 1287 | 1.27 |
| 02:54 ET | 1359 | 1.28 |
| 02:56 ET | 800 | 1.28 |
| 02:58 ET | 100 | 1.28 |
| 03:02 ET | 300 | 1.28 |
| 03:07 ET | 220 | 1.28 |
| 03:14 ET | 5157 | 1.27 |
| 03:16 ET | 700 | 1.28 |
| 03:21 ET | 2120 | 1.28 |
| 03:25 ET | 100 | 1.29 |
| 03:27 ET | 146 | 1.28 |
| 03:30 ET | 2762 | 1.27 |
| 03:32 ET | 100 | 1.29 |
| 03:34 ET | 822 | 1.29 |
| 03:36 ET | 184 | 1.29 |
| 03:38 ET | 200 | 1.29 |
| 03:39 ET | 1293 | 1.285 |
| 03:41 ET | 5657 | 1.28 |
| 03:43 ET | 300 | 1.28 |
| 03:45 ET | 2347 | 1.29 |
| 03:48 ET | 500 | 1.29 |
| 03:50 ET | 4201 | 1.29 |
| 03:52 ET | 900 | 1.29 |
| 03:54 ET | 6252 | 1.305 |
| 03:56 ET | 8771 | 1.33 |
| 03:57 ET | 400 | 1.32 |
| 03:59 ET | 12453 | 1.33 |
Apr 10, 2024
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum, from 8:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ikena Oncology Inc | 64.2M | -0.8x | --- |
Correlate Energy Corp | 60.2M | -4.2x | --- |
Collplant Biotechnologies Ltd | 59.6M | -8.2x | --- |
Atara Biotherapeutics Inc | 78.9M | -0.3x | --- |
Kezar Life Sciences Inc | 57.5M | -0.6x | --- |
Kronos Bio Inc | 60.7M | -0.5x | --- |
Company Information
Ikena Oncology, Inc. is a targeted oncology company. The Company is focused on developing differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. The Company's lead targeted oncology program, IK-930, is a transcriptional enhanced associate domain 1 (TEAD1) selective Hippo pathway inhibitor, a known tumor suppressor pathway that also drives resistance to multiple targeted therapies. The Company's second clinical-stage program targets the RAS signaling pathway with IK-595, a novel MEK-RAF molecular glue. It has IK-175 aryl hydrocarbon receptor (AHR) antagonist program that completed Phase 1 clinical trial. Its partnering portfolio also includes several other immune oncology programs that are available for potential sale or outlicensing, including PY314, a Phase 2 ready TREM2 antagonist, PY159, a Phase 2 ready TREM1 antagonist, and PY265, an IND-ready MARCO antagonist.
Contact Information
- Headquarters
- 50 Northern Ave.BOSTON, MA, United States 02210
- Phone
- 857-343-8292
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Owen Hughes
- President, Chief Executive Officer, Director
- Mark Manfredi
- Chief Financial Officer, Head of Corporate Development
- Jotin Marango
- Chief Scientific Officer
- Michelle Zhang
- Chief Development Officer
- Jeffrey Ecsedy
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $64.2M |
|---|---|
Revenue (TTM) | $9.2M |
Shares Outstanding | 48.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.63 |
Book Value | $3.52 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 7.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -823.23% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
